Nwk Group, Inc. Astrazeneca PLC Transaction History

Nwk Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $2.46 Million - $2.95 Million	-50,773 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $71,326 - $82,118	1,344 Added 2.72%	50,773 $2.78 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $2.13 Million - $2.73 Million	49,429 New	49,429 $2.61 Million

1,368

512M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $230B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nwk Group, Inc. with notifications on news.